126 related articles for article (PubMed ID: 19702629)
21. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.
Fielder J; Rambiki K
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404
[TBL] [Abstract][Full Text] [Related]
22. Matched case-control study to evaluate risk factors for hyperlactataemia in HIV patients on antiretroviral therapy.
Datta D; Moyle G; Mandalia S; Gazzard B
HIV Med; 2003 Oct; 4(4):311-4. PubMed ID: 14525541
[TBL] [Abstract][Full Text] [Related]
23. Fatal lactic acidosis during antiretroviral therapy.
Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
[TBL] [Abstract][Full Text] [Related]
24. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
Khouri S; Cushing H
AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
[TBL] [Abstract][Full Text] [Related]
25. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
26. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
[TBL] [Abstract][Full Text] [Related]
27. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
[TBL] [Abstract][Full Text] [Related]
28. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
[TBL] [Abstract][Full Text] [Related]
29. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
Shah SS; Rodriguez T; McGowan JP
Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003.
Bonnet F; Balestre E; Bernardin E; Pellegrin JL; Neau D; Dabis F;
Antivir Chem Chemother; 2005; 16(1):63-7. PubMed ID: 15739622
[TBL] [Abstract][Full Text] [Related]
32. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.
Lichtenstein KA; Armon C; Baron A; Moorman AC; Wood KC; Holmberg SD;
Clin Infect Dis; 2005 Jan; 40(1):148-57. PubMed ID: 15614705
[TBL] [Abstract][Full Text] [Related]
33. A high incidence of nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis in HIV-infected patients in a South African context.
Geddes R; Knight S; Moosa MY; Reddi A; Uebel K; Sunpath H
S Afr Med J; 2006 Aug; 96(8):722-4. PubMed ID: 17019496
[TBL] [Abstract][Full Text] [Related]
34. d4T plus ddI: warning for pregnant women.
AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
[TBL] [Abstract][Full Text] [Related]
35. [Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy].
Justesen US; Pedersen C
Ugeskr Laeger; 2000 Aug; 162(35):4664-5. PubMed ID: 10986895
[TBL] [Abstract][Full Text] [Related]
36. HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
Maritz J; Benatar M; Dave JA; Harrison TB; Badri M; Levitt NS; Heckmann JM
Muscle Nerve; 2010 May; 41(5):599-606. PubMed ID: 20229576
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
38. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore.
Hwang SW; Leo YS
Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 prevalence and risk factors among sexually transmitted disease clinic attenders in Trinidad.
Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; White F; Bartholomew C; Blattner WA
AIDS; 1995 Apr; 9(4):389-94. PubMed ID: 7794544
[TBL] [Abstract][Full Text] [Related]
40. Lactic acidosis associated with severe neuromuscular weakness and stavudine therapy.
Vorasayan P; Phanthumchinda K
J Med Assoc Thai; 2011 Apr; 94(4):501-4. PubMed ID: 21591538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
